{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:23:14Z","timestamp":1791328994487,"version":"4.3.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.biochi.2014.06.007","type":"journal-article","created":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T11:39:25Z","timestamp":1403091565000},"page":"143-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"PA","title":["Development of antileishmanial lipid nanocomplexes"],"prefix":"10.1016","volume":"107","author":[{"given":"T.T.H.","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gueutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cheron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Chaminade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"Loiseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Barratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2014.06.007_bib1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0738-081X(96)00057-0","article-title":"Leishmaniasis: public health aspects and control","volume":"14","author":"Desjeux","year":"1996","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.biochi.2014.06.007_bib2","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.biochi.2014.06.007_bib3","first-page":"305","article-title":"Leishmaniasis: current situation and new perspectives, comparative immunology","volume":"27","author":"Desjeux","year":"2004","journal-title":"Microbiol. Infect. Dis."},{"key":"10.1016\/j.biochi.2014.06.007_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0035-9203(01)90223-8","article-title":"The increase in risk factors for leishmaniasis worldwide","volume":"95","author":"Desjeux","year":"2001","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.biochi.2014.06.007_bib5","first-page":"951","article-title":"Laboratory diagnosis of visceral leishmaniasis","volume":"9","author":"Sundar","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.biochi.2014.06.007_bib6","series-title":"Advances in Parasitology","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0065-308X(05)61006-8","article-title":"Chemotherapy in the treatment and control of leishmaniasis","author":"Alvar","year":"2006"},{"key":"10.1016\/j.biochi.2014.06.007_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11908-005-0021-1","article-title":"Recent developments in leishmaniasis: epidemiology, diagnosis, and treatment","volume":"7","author":"Berman","year":"2005","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.biochi.2014.06.007_bib8","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(98)04367-0","article-title":"Trial of oral miltefosine for visceral leishmaniasis","volume":"352","author":"Sundar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.biochi.2014.06.007_bib9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda","volume":"2","author":"Guerin","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.biochi.2014.06.007_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drup.2006.04.001","article-title":"Mechanisms of experimental resistance of Leishmania to miltefosine: implications for clinical use","volume":"9","author":"P\u00e9rez-Victoria","year":"2006","journal-title":"Drug. Resist. Updat."},{"key":"10.1016\/j.biochi.2014.06.007_bib11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0005-2736(75)90299-0","article-title":"Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles","volume":"394","author":"Papahadjopoulos","year":"1975","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Biomembranes"},{"key":"10.1016\/j.biochi.2014.06.007_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1978.tb22013.x","article-title":"Calcium-induced lipid phase transition and membrane fusion","volume":"308","author":"Papahadjopoulos","year":"1978","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biochi.2014.06.007_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0076-6879(05)91018-5","article-title":"Drug delivery by lipid cochleates","volume":"391","author":"Zarif","year":"2005","journal-title":"Meth. Enzymol."},{"key":"10.1016\/j.biochi.2014.06.007_bib14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0169-409X(98)00014-3","article-title":"Targeting immune response induction with cochleate and liposome-based vaccines","volume":"32","author":"Mannino","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biochi.2014.06.007_bib15","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/AAC.44.9.2356-2360.2000","article-title":"Efficacy of oral cochleate-Amphotericin B in a mouse model of systemic candidiasis","volume":"44","author":"Santangelo","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biochi.2014.06.007_bib16","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1128\/AAC.44.6.1463-1469.2000","article-title":"Antifungal activity of Amphotericin B cochleates against Candida albicans infection in a mouse model","volume":"44","author":"Zarif","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biochi.2014.06.007_bib17","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1128\/AAC.46.8.2704-2707.2002","article-title":"Efficacy of orally delivered cochleates containing Amphotericin B in a murine model of aspergillosis","volume":"46","author":"Delmas","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biochi.2014.06.007_bib18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/08982100009031116","article-title":"Cochleates: new lipid-based drug delivery system","volume":"10","author":"Zarif","year":"2000","journal-title":"J.\u00a0Liposome Res."},{"key":"10.1016\/j.biochi.2014.06.007_bib19","unstructured":"T. Jin, L. Zarif, R.J. Mannino, Nano-cochleate formulations, process of preparation and method of delivery of pharmaceutical agents, U.S.A., 2000."},{"key":"10.1016\/j.biochi.2014.06.007_bib20","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1128\/AAC.00837-06","article-title":"Interaction between miltefosine and amphotericin B: consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in\u00a0vitro","volume":"50","author":"M\u00e9nez","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biochi.2014.06.007_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jchromb.2008.02.005","article-title":"Development and validation of a quantitative assay for the measurement of miltefosine in human plasma by liquid chromatography\u2013tandem mass spectrometry","volume":"865","author":"Dorlo","year":"2008","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.biochi.2014.06.007_bib22","unstructured":"US Pharmacopeia, U. Rockville, MD, 2006."},{"key":"10.1016\/j.biochi.2014.06.007_bib23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbamem.2004.01.010","article-title":"Hexadecylphosphocholine interaction with lipid monolayers","volume":"1661","author":"Rakotomanga","year":"2004","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Biomembranes"},{"key":"10.1016\/j.biochi.2014.06.007_bib24","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/S0006-3495(97)78905-7","article-title":"Bending elasticities of model membranes: influences of temperature and sterol content","volume":"72","author":"M\u00e9l\u00e9ard","year":"1997","journal-title":"Biophys. J."},{"key":"10.1016\/j.biochi.2014.06.007_bib25","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.bbamem.2009.06.019","article-title":"Effect of sterol structure on the bending rigidity of lipid membranes: a 2H NMR transverse relaxation study","volume":"1788","author":"Or\u00e4dd","year":"2009","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Biomembranes"},{"key":"10.1016\/j.biochi.2014.06.007_bib26","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.chemphyslip.2012.04.001","article-title":"Selective partitioning of cholesterol and a model drug into liposomes of varying size","volume":"165","author":"Decker","year":"2012","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.biochi.2014.06.007_bib27","doi-asserted-by":"crossref","first-page":"021931","DOI":"10.1103\/PhysRevE.80.021931","article-title":"Effect of cholesterol on structural and mechanical properties of membranes depends on lipid chain saturation","volume":"80","author":"Pan","year":"2009","journal-title":"Phys. Rev. E Stat. Nonlin. Soft Matter Phys."},{"key":"10.1016\/j.biochi.2014.06.007_bib28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.colsurfb.2013.01.041","article-title":"Interactions of antileishmanial drugs with monolayers of lipids used in the development of amphotericin B-miltefosine-loaded nanocochleates","volume":"106","author":"Pham","year":"2013","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biochi.2014.06.007_bib29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejps.2006.04.016","article-title":"Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system","volume":"29","author":"Pouton","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biochi.2014.06.007_bib30","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.addr.2007.05.003","article-title":"Nanosizing-oral formulation development and biopharmaceutical evaluation","volume":"59","author":"Kesisoglou","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biochi.2014.06.007_bib31","series-title":"Hydrogel-isolated Cochleate Formulations, Process of Preparation and Their Use for the Delivery of Biologically Relevant Molecules","author":"Zarif","year":"2003"},{"key":"10.1016\/j.biochi.2014.06.007_bib32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0003-9861(85)90498-9","article-title":"Preservation of freeze-dried liposomes by trehalose","volume":"242","author":"Crowe","year":"1985","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biochi.2014.06.007_bib33","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1016\/0006-2952(84)90156-4","article-title":"Effect of surface curvature on the interaction of single lamellar phospholipid vesicles with aromatic and nonaromatic heptaene antibiotics (vacidin A and amphotericin B)","volume":"33","author":"Bolard","year":"1984","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biochi.2014.06.007_bib34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0927-7765(98)00033-2","article-title":"Interaction of amphotericin B with polymeric colloids: a spectroscopic study","volume":"11","author":"Espuelas","year":"1998","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biochi.2014.06.007_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0927-7765(98)00035-6","article-title":"Interaction of amphotericin B with polymeric colloids: 2. Effect of poloxamer on the adsorption of amphotericin B onto poly(epsilon-caprolactone) nanospheres","volume":"11","author":"Espuelas","year":"1998","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biochi.2014.06.007_bib36","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/AAC.41.11.2345","article-title":"Heat-induced superaggregation of amphotericin B reduces its in\u00a0vitro toxicity: a new way to improve its therapeutic index","volume":"41","author":"Gaboriau","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biochi.2014.06.007_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/jcis.1993.1230","article-title":"Spontaneous organization of Amphotericin B in aqueous medium","volume":"158","author":"Barwicz","year":"1993","journal-title":"J.\u00a0Colloid Interface Sci."},{"key":"10.1016\/j.biochi.2014.06.007_bib38","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/AAC.36.11.2518","article-title":"Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes","volume":"36","author":"Legrand","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biochi.2014.06.007_bib39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/10611869708995847","article-title":"Release of amphotericin B from delivery systems and its action against fungal and mammalian cells","volume":"4","author":"Legrand","year":"1997","journal-title":"J.\u00a0Drug Target"},{"key":"10.1016\/j.biochi.2014.06.007_bib40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2174\/1389203003381315","article-title":"The use of circular dichroism in the investigation of protein structure and function","volume":"1","author":"Kelly","year":"2000","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.biochi.2014.06.007_bib41","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0005-2736(80)90074-7","article-title":"Interaction between phospholipid bilayer membranes and the polyene antibiotic amphotericin B: lipid state and cholesterol content dependence","volume":"599","author":"Bolard","year":"1980","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Biomembranes"},{"key":"10.1016\/j.biochi.2014.06.007_bib42","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1139\/o82-097","article-title":"Association of the polyene antibiotic amphotericin B with phospholipid vesicles: perturbation by temperature changes","volume":"60","author":"Bolard","year":"1982","journal-title":"Can. J. Biochem."},{"key":"10.1016\/j.biochi.2014.06.007_bib43","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1021\/bi00237a011","article-title":"One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium","volume":"30","author":"Bolard","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2014.06.007_bib44","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1021\/bi00281a024","article-title":"Differences in the interaction of the polyene antibiotic amphotericin B with cholesterol- or ergosterol-containing phospholipid vesicles. A circular dichroism and permeability study","volume":"22","author":"Vertut-Croquin","year":"1983","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2014.06.007_bib45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0009-3084(02)00005-1","article-title":"The effect of metal cations on the phase behavior and hydration characteristics of phospholipid membranes","volume":"115","author":"Binder","year":"2002","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.biochi.2014.06.007_bib46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0169-409X(96)00488-7","article-title":"Structure and function of gastro-intestinal lipases","volume":"25","author":"Embleton","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biochi.2014.06.007_bib47","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ejpb.2008.09.004","article-title":"Solubilisation of dipalmitoylphosphatidylcholine bilayers by sodium taurocholate: a model to study the stability of liposomes in the gastrointestinal tract and their mechanism of interaction with a model bile salt","volume":"71","author":"Andrieux","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biochi.2014.06.007_bib48","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/10611869808997864","article-title":"Liposomal formulations for oral immunotherapy: in-vitro stability in synthetic intestinal media and in-vivo efficacy in the mouse","volume":"5","author":"Ouadahi","year":"1998","journal-title":"J.\u00a0Drug Target"},{"key":"10.1016\/j.biochi.2014.06.007_bib49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF03190714","article-title":"Pharmacology of bile acids and their derivatives: absorption promoters and therapeutic agents","volume":"31","author":"Mikov","year":"2006","journal-title":"Eur. J. Drug. Metab. Pharmacokinet."},{"key":"10.1016\/j.biochi.2014.06.007_bib50","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/03639049809082364","article-title":"Effect of various lipid-bile salt mixed micelles on the intestinal absorption of Amphotericin B in rat","volume":"24","author":"Dangi","year":"1998","journal-title":"Drug. Dev. Ind. Pharm."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908414001503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908414001503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T13:17:23Z","timestamp":1565529443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908414001503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":50,"alternative-id":["S0300908414001503"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2014.06.007","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of antileishmanial lipid nanocomplexes","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2014.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}